Page last updated: 2024-10-28

gyki 52466 and Subarachnoid Hemorrhage

gyki 52466 has been researched along with Subarachnoid Hemorrhage in 1 studies

GYKI 52466: an AMPA (non-NMDA) receptor antagonist; structure given in first source

Subarachnoid Hemorrhage: Bleeding into the intracranial or spinal SUBARACHNOID SPACE, most resulting from INTRACRANIAL ANEURYSM rupture. It can occur after traumatic injuries (SUBARACHNOID HEMORRHAGE, TRAUMATIC). Clinical features include HEADACHE; NAUSEA; VOMITING, nuchal rigidity, variable neurological deficits and reduced mental status.

Research Excerpts

ExcerptRelevanceReference
" In the present study the activity of bimoclomol was tested in experimental subarachnoid hemorrhage (SAH) and arachidonic acid (AA)-induced brain edema in rats to elucidate whether the compound may also have beneficial effect in cerebrovascular disturbances."7.70Bimoclomol protects against vascular consequences of experimental subarachnoid hemorrhage in rats. ( Erdö, F; Erdö, SL, 1998)
" In the present study the activity of bimoclomol was tested in experimental subarachnoid hemorrhage (SAH) and arachidonic acid (AA)-induced brain edema in rats to elucidate whether the compound may also have beneficial effect in cerebrovascular disturbances."3.70Bimoclomol protects against vascular consequences of experimental subarachnoid hemorrhage in rats. ( Erdö, F; Erdö, SL, 1998)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Erdö, F1
Erdö, SL1

Other Studies

1 other study available for gyki 52466 and Subarachnoid Hemorrhage

ArticleYear
Bimoclomol protects against vascular consequences of experimental subarachnoid hemorrhage in rats.
    Brain research bulletin, 1998, Volume: 45, Issue:2

    Topics: Animals; Anti-Anxiety Agents; Arachidonic Acid; Benzodiazepines; Brain Edema; Cerebral Angiography;

1998